Investment
Features
FeesSafety
Academy
More
Pluang+

Prospect Markets to present at Cantech Conference and plans stock option repricing to retain key staff

Company Fundamentals
02 Oct 2026
Newsfile Corp
View Source
Neutral
Prospect Markets to present at Cantech Conference and plans stock option repricing to retain key staff

Prospect Prediction Markets Inc. will present at the 9th Annual Cantech Investment Conference in Toronto on October 8, 2026. The company also plans to reprice 2,050,000 stock options for certain officers, employees, and consultants from $0.41-$0.65 to $0.31 per share, pending TSX Venture Exchange approval and shareholder consent. This repricing aims to align interests between the company's team and shareholders and help retain key personnel. The repricing will only take effect after all approvals are received, and the company’s CEO Johnny Chen will be available for investor meetings at the conference.

Prospect Prediction Markets Inc. is in the spotlight with data from Pluang's Technology sector as of Oct 02, 2026 14:11 WIB. For readers following this sector, here is Pluang's market snapshot: out of 150 priced US Technology stocks, 120 rose and 27 fell today. Notable movers include VERI at USD 0.79 with a 1-day change of +5.00%, TASK at USD 8.22 with +4.98%, and PAYC at USD 227.50 with +4.53%.

More News

Ford recalls over 40,000 vehicles for headlight defect risking driver visibility and safety

Ford recalls over 40,000 vehicles for headlight defect risking driver visibility and safety

Ford is recalling about 41,748 vehicles from model years 2025 to 2027, including Ford Expedition and several Ford Super Duty trucks, due to a headlight defect. The issue involves contaminated LED chips that can cause loss of various exterior lights, ...

Market News
Bearish
4 hours ago
Eli Lilly's new obesity drug shows stronger weight loss than Novo Nordisk's, raising market competition.

Eli Lilly's new obesity drug shows stronger weight loss than Novo Nordisk's, raising market competition.

Eli Lilly announced promising mid-stage trial results for EloraTZP, a new obesity drug that led to up to 23.3% weight loss in overweight or obese type 2 diabetes patients after 48 weeks, outperforming Novo Nordisk's tirzepatide alone. The drug also s...

Market News
Neutral
4 hours ago
SSE maintains £33bn investment plan with strong network growth, Jefferies keeps 'buy' rating

SSE maintains £33bn investment plan with strong network growth, Jefferies keeps 'buy' rating

SSE PLC confirmed it is on track with its £33 billion investment programme, supported by a sharp rise in network investment, especially in transmission. Jefferies retained its 'buy' rating and 3,060p price target, seeing a 23% upside from current lev...

Company Fundamentals
Bullish
4 hours ago
Bitcoin price edges above $86,000 on Binance spot market early Oct 2

Bitcoin price edges above $86,000 on Binance spot market early Oct 2

Bitcoin briefly rose above $86,000, reaching $86,021 on Binance's spot market early on October 2. This small increase followed a price of $85,988 just 15 minutes earlier, marking a 0.02% gain over the previous hour. As the largest cryptocurrency by m...

Market News
Bullish
4 hours ago
Oil-Dri stock soars 599% since 2022 but now rated Hold as valuation peaks

Oil-Dri stock soars 599% since 2022 but now rated Hold as valuation peaks

Oil-Dri Corporation of America has delivered a remarkable 599% return since August 2022, driven by strong cat litter sales, expanding distribution, and operational improvements. Despite this growth and operational excellence, the stock is now conside...

Analyst Insights
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App